John Cao, PharmD, BCPS

NYU Langone Health

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1809 - Treatment Outcomes in Piperacillin-tazobactam Non-susceptible (TZP-NS)/Ceftriaxone Susceptible (CRO-S) Infections
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET